How Wolbachia bacteria help mosquitoes stop viruses
Identifying Wolbachia effectors that facilitate host infection
Researchers are identifying bacterial proteins Wolbachia uses to live inside Aedes mosquitoes so Wolbachia releases can better protect communities from dengue, Zika, and other mosquito-borne viruses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Trustees of Indiana University NIH-funded |
| Lab location | 1 site (Bloomington, United States) |
| Project ID | NIH-11283946 on NIH RePORTER |
What this research studies
This project studies Wolbachia, a naturally occurring bacterium that can block RNA viruses inside Aedes aegypti mosquitoes. Scientists use live imaging, proteomics, and molecular tools to find the bacterial 'effectors' Wolbachia secretes through its type IV secretion system and to see how these proteins change mosquito cells. They compare these secreted proteins across Wolbachia strains and test how they affect bacterial colonization and maternal transmission in mosquitoes. From a community perspective, understanding these mechanisms could help make Wolbachia releases more reliable at reducing dengue, Zika, and chikungunya.
Who could benefit from this research
Good fit: People living in areas with Aedes aegypti–transmitted viruses or communities targeted for Wolbachia mosquito release programs are the most likely to benefit.
Not a fit: Individuals currently sick with an arboviral infection are unlikely to receive direct medical benefit from this laboratory-focused research.
Why it matters
Potential benefit: Could improve Wolbachia-based mosquito control programs so fewer people get dengue, Zika, and other arboviral infections.
How similar studies have performed: Field programs releasing Wolbachia-infected mosquitoes have reduced dengue transmission in some locations, but pinpointing the specific Wolbachia proteins that enable stable mosquito colonization is a newer and less-tested area.
Where this research is happening
Bloomington, United States
- Trustees of Indiana University — Bloomington, United States (Active)
Researchers
- Principal investigator: Newton, Irene — Trustees of Indiana University
- Study coordinator: Newton, Irene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.